Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma

[1]  Atique U. Ahmed,et al.  Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy , 2014, Expert opinion on drug delivery.

[2]  Yi-ye Zhou,et al.  Integration-free Methods for Generating Induced Pluripotent Stem Cells , 2013, Genom. Proteom. Bioinform..

[3]  Rex A. Moats,et al.  Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies , 2013, Science Translational Medicine.

[4]  Marius Wernig,et al.  The many roads to Rome: induction of neural precursor cells from fibroblasts. , 2012, Current opinion in genetics & development.

[5]  Xiao Luo,et al.  The Roles of Hypoxia-Inducible Factors in Regulating Neural Stem Cells Migration to Glioma Stem Cells and Determinating Their Fates , 2012, Neurochemical Research.

[6]  S. Vajda,et al.  A First-Generation Multi-Functional Cytokine for Simultaneous Optical Tracking and Tumor Therapy , 2012, PloS one.

[7]  Anatol C. Kreitzer,et al.  Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. , 2012, Cell stem cell.

[8]  R. Yasuda,et al.  Nonviral Direct Conversion of Primary Mouse Embryonic Fibroblasts to Neuronal Cells , 2012, Molecular therapy. Nucleic acids.

[9]  C. Miller,et al.  Genetically engineered mouse models of diffuse gliomas , 2012, Brain Research Bulletin.

[10]  J. C. Belmonte,et al.  Induced neural stem cells: a new tool for studying neural development and neurological disorders , 2012, Cell Research.

[11]  Dong Wook Han,et al.  Direct reprogramming of fibroblasts into neural stem cells by defined factors. , 2012, Cell stem cell.

[12]  M. Nöthen,et al.  Direct conversion of fibroblasts into stably expandable neural stem cells. , 2012, Cell stem cell.

[13]  Marius Wernig,et al.  Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells , 2012, Proceedings of the National Academy of Sciences.

[14]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[15]  K. Shah,et al.  Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas , 2011, Nature Neuroscience.

[16]  Shigang He,et al.  Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors , 2011, Cell Research.

[17]  K. Shah,et al.  Real-time multi-modality imaging of glioblastoma tumor resection and recurrence , 2012, Journal of Neuro-Oncology.

[18]  K. Shah,et al.  Migration and fate of therapeutic stem cells in different brain disease models , 2011, Neuroscience.

[19]  Atique U. Ahmed,et al.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. , 2011, Molecular pharmaceutics.

[20]  S. Temple,et al.  Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta Stone , 2011, Neuron.

[21]  S. Lipton,et al.  Direct reprogramming of mouse fibroblasts to neural progenitors , 2011, Proceedings of the National Academy of Sciences.

[22]  Atique U. Ahmed,et al.  The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. , 2010, Current opinion in molecular therapeutics.

[23]  W. El-Deiry,et al.  TRAIL receptor signaling and therapeutics , 2010, Expert opinion on therapeutic targets.

[24]  C. Kruse,et al.  An improved, standardised protocol for the isolation, enrichment and targeted neural differentiation of Nestin+ progenitors from adult human dermis , 2010, Experimental dermatology.

[25]  Serban Nacu,et al.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.

[26]  R. Weissleder,et al.  A Novel Molecule Integrating Therapeutic and Diagnostic Activities Reveals Multiple Aspects of Stem Cell‐based Therapy , 2010, Stem cells.

[27]  H. Armah.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial , 2010 .

[28]  D. Bigner,et al.  Glioblastoma multiforme: a review of where we have been and where we are going , 2009, Expert opinion on investigational drugs.

[29]  E. Snyder,et al.  Role of monocyte chemoattractant protein‐1 (MCP‐1/CCL2) in migration of neural progenitor cells toward glial tumors , 2009, Journal of neuroscience research.

[30]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[31]  Khalid Shah,et al.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. , 2009, Cancer research.

[32]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[33]  C. Glackin,et al.  Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia , 2008, Molecular Cancer Research.

[34]  R. Weissleder,et al.  Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide , 2008, Molecular Cancer Therapeutics.

[35]  Yuan Hong Yu,et al.  Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. , 2008, Cancer research.

[36]  M. Danks,et al.  Stem and progenitor cell-mediated tumor selective gene therapy , 2008, Gene Therapy.

[37]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[38]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[39]  R. Sidman,et al.  Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: Evidence from the effect of hypoxia–ischemia in the CNS on clonal “reporter” neural stem cells , 2006, Experimental Neurology.

[40]  T. Crombleholme,et al.  Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.

[41]  Bryan Heit,et al.  Measuring Chemotaxis and Chemokinesis: The Under-Agarose Cell Migration Assay , 2003, Science's STKE.

[42]  K. Black,et al.  The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. , 2002, Cancer research.